Stock Exchange Communication


IN THIS SECTION

Stock Exchange Intimations

February
08 February, 2023

Stock Exchange Intimation for Transcript of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022

08 February, 2023

Corrigendum to our letter dated February 1, 2023 intimating the re-appointment of Directors

07 February, 2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

02 February, 2023

Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

02 February, 2023

Audio Recording of Analysts/Investors Call pertaining to the Financial Results for the third quarter and nine months ended December 31, 2022

02 February, 2023

Newspaper Advertisement - Audited Standalone and Unaudited Consolidated Financial Results for the third quarter and nine months ended December 31, 2022

Shareholding Pattern

Shareholding Pattern as on December 31, 2022

Shareholding pattern as on September 30, 2022

Shareholding pattern as on June 2022

Quarterly Corporate Governance Reports

Corporate Governance Report as on December 31, 2022

Corporate Governance Report as on September 30, 2022

Corporate Governance Report as on June 30, 2022

Related Party Transactions

Disclosure of Related Party Transactions for the half year ended September 30, 2022 pursuant to Regulation 23(9) of the SEBI Listing Regulations

Investors Contact

Mr Rajiv Chandan

General Counsel & Company Secretary

Phone

91-22-66658282

Mr Sriram Srinivasan

Chief Risk Officer & Head - Strategic Finance

Phone

91-22-66658282

Tata Chemicals Limited

Registered Office

24, Bombay House, Homi Mody Street, Fort,Mumbai 400 001, India

CIN: L24239MH1939PLC002893